MACQUARIE GROUP LTD - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 165 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$18,000
-41.9%
28,0770.0%0.00%
Q4 2021$31,000
-39.2%
28,0770.0%0.00%
Q3 2021$51,000
+218.8%
28,077
+350.8%
0.00%
Q2 2021$16,000
-27.3%
6,2280.0%0.00%
Q1 2021$22,000
+4.8%
6,228
-23.5%
0.00%
Q4 2020$21,0000.0%8,1380.0%0.00%
Q3 2020$21,000
-22.2%
8,1380.0%0.00%
Q2 2020$27,0008,1380.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 12,546,493$22,835,0001.71%
MSD Partners, L.P. 15,151,516$27,576,0000.84%
MSD Partners, L.P. 7,575,758$13,788,0000.42%
CHIRON CAPITAL MANAGEMENT, LLC 198,002$360,0000.26%
Avidity Partners Management LP 3,000,000$5,460,0000.12%
Old West Investment Management, LLC 211,513$384,0000.10%
MAGNOLIA CAPITAL ADVISORS LLC 103,239$188,0000.07%
Virtus ETF Advisers LLC 72,060$131,0000.06%
ACT WEALTH MANAGEMENT, LLC 34,454$91,0000.06%
Allred Capital Management, LLC 53,000$96,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders